Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Novel Hepatitis B DNA Test from Capillary Blood At the Point-of-care As a Tool to Enhance Clinical Management

NCT05144776 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT05144776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Novel Hepatitis B DNA Test from Capillary Blood At the Point-of-care As a Tool to Enhance Clinical Management
Lead sponsor
Kirby Institute
Phase
Observational
Overall status
Completed
Start date
November 17, 2022
Completion date
June 5, 2024
Enrollment
268 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b